ATLASGRI Bio (GRI) earnings date: Nov 13, 2026
GRI Bio (GRI) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.84.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on GRI
| Last price | $1.57 (+2.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the GRI Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
GRI Bio reports on Nov 13, 2026. One email the day before, with ATLAS’s read on GRI Bio. You can switch it off at any time.
Alert me before GRI reportsFree to start. Creating an account takes under a minute.
Notify me when GRI Bio reports
Track GRI free Add GRI Bio to a free ATLAS watchlist and see its next report date in one place.
GRI earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.84 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -46.7% |
| Average move around a report | ±6.8% (last 5) |
| Sector | Healthcare · Biotechnology |
GRI Bio earnings history: last 5 reports
GRI Bio last reported on Aug 14, 2026: EPS of -$0.91 against an estimate of -$1.19 (+23.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$1.19 | -$0.91 | +23.5% | Beat | -2.3% |
| May 13, 2026 | -$3.74 | -$1.61 | +57.0% | Beat | -5.7% |
| Jan 30, 2026 | -$29.26 | -$116.61 | -298.5% | Miss | -13.9% |
| Nov 14, 2025 | -$31.08 | -$35.84 | -15.3% | Miss | -5.3% |
| Aug 14, 2025 | -$36.68 | -$36.68 | 0.0% | In line | +6.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for GRI
See the fair value, the probability range and the earnings history of GRI Bio on its ATLAS page.
GRI Bio (GRI) stock analysisPlans from €3.99 a month.
GRI Bio earnings: frequently asked questions
When does GRI Bio (GRI) report earnings?
GRI Bio is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for GRI?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.84 per share (USD). Estimates can change before the report.
How often does GRI beat earnings estimates?
Of its last 5 reports with a recorded result, GRI Bio beat the EPS estimate 2 times; the average surprise was -46.7%. Past results do not predict the next one.
How much does GRI move around earnings?
Over its last 5 reports the stock moved an average of 6.8% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did GRI Bio beat earnings estimates last quarter?
GRI Bio last reported on Aug 14, 2026: EPS of -$0.91 against an estimate of -$1.19 (+23.5% surprise), a beat.
How much does GRI usually move in a day?
On a normal trading day the ATLAS model puts GRI’s one-day range at about ±5.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer